In the Phase 2 obesity trial, the 12 mg weekly dose produced a mean weight reduction of about 24.2% at 48 weeks ( Jastreboff et al., NEJM 2023 ) the largest figure reported for any single agent in the incretin class at the time
Medical Weight Loss Programs with Emerging Treatment Options Telemedicine Consultations, Treatment Education, and Provider-Guided Care for Eligible Patients Inside the Research: Retatrutide and the Future of Metabolic Science WHAT RETATRUTIDE MEANS FOR PATIENTS RIGHT NOW How Triple-Receptor Research Is Being Studied GLP-1 GLP-1 pathways are involved in appetite, digestion, and blood sugar regulation
10.1021/acsnano.8b06201 76 ShiM.FortinD.PaquetteB.SancheL
Lean mass stabilized between months 712, with an overall ~3 kg loss
Seek medical advice if sulphur burps persist beyond the first 8-12 weeks of treatment or worsen over time despite dietary modifications
I have returned a few times and will continue to use them! Brittany Ballard Dr